FR2710845B1 - Composition destinée à l'immunothérapie d'un cancer sécrétant l'hCG ou des fragments d'hCG. - Google Patents

Composition destinée à l'immunothérapie d'un cancer sécrétant l'hCG ou des fragments d'hCG.

Info

Publication number
FR2710845B1
FR2710845B1 FR9312039A FR9312039A FR2710845B1 FR 2710845 B1 FR2710845 B1 FR 2710845B1 FR 9312039 A FR9312039 A FR 9312039A FR 9312039 A FR9312039 A FR 9312039A FR 2710845 B1 FR2710845 B1 FR 2710845B1
Authority
FR
France
Prior art keywords
hcg
immunotherapy
fragments
composition intended
cancer secreting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9312039A
Other languages
English (en)
Other versions
FR2710845A1 (fr
Inventor
Dominique Bellet
Frederic Troalen
Nathalie Rouas-Freiss
Jean-Michel Bidart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cephalon France SAS
Original Assignee
Laboratoire L Lafon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9312039A priority Critical patent/FR2710845B1/fr
Application filed by Laboratoire L Lafon SA filed Critical Laboratoire L Lafon SA
Priority to JP6519675A priority patent/JPH08507604A/ja
Priority to AU62112/94A priority patent/AU6211294A/en
Priority to CA002157868A priority patent/CA2157868A1/fr
Priority to NZ262435A priority patent/NZ262435A/en
Priority to PCT/FR1994/000265 priority patent/WO1994020859A1/fr
Priority to EP94909172A priority patent/EP0688432A1/fr
Priority to PCT/FR1994/001177 priority patent/WO1995010299A1/fr
Priority to AU79413/94A priority patent/AU7941394A/en
Publication of FR2710845A1 publication Critical patent/FR2710845A1/fr
Application granted granted Critical
Publication of FR2710845B1 publication Critical patent/FR2710845B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001144—Hormones, e.g. calcitonin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR9312039A 1993-03-11 1993-10-08 Composition destinée à l'immunothérapie d'un cancer sécrétant l'hCG ou des fragments d'hCG. Expired - Fee Related FR2710845B1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR9312039A FR2710845B1 (fr) 1993-10-08 1993-10-08 Composition destinée à l'immunothérapie d'un cancer sécrétant l'hCG ou des fragments d'hCG.
AU62112/94A AU6211294A (en) 1993-03-11 1994-03-10 Kit for diagnosing an hcg- or hcg fragment-secreting cancer and immunotherapeutical means therefor
CA002157868A CA2157868A1 (fr) 1993-03-11 1994-03-10 Trousse de diagnostic d'un cancer secretant l'hcg ou des fragments d'hcg et moyens destines a l'immunotherapie d'un tel cancer
NZ262435A NZ262435A (en) 1993-03-11 1994-03-10 Kit for diagnosing an hcg fragment secreting cancer and immunotherapeutical means therefor
JP6519675A JPH08507604A (ja) 1993-03-11 1994-03-10 ｈＣＧまたはｈＣＧのフラグメントを分泌する癌に対する診断用キットおよびかような癌の免疫療法用手段
PCT/FR1994/000265 WO1994020859A1 (fr) 1993-03-11 1994-03-10 TROUSSE DE DIAGNOSTIC D'UN CANCER SECRETANT L'hCG OU DES FRAGMENTS D'hCG ET MOYENS DESTINES A L'IMMUNOTHERAPIE D'UN TEL CANCER
EP94909172A EP0688432A1 (fr) 1993-03-11 1994-03-10 TROUSSE DE DIAGNOSTIC D'UN CANCER SECRETANT L'hCG OU DES FRAGMENTS D'hCG ET MOYENS DESTINES A L'IMMUNOTHERAPIE D'UN TEL CANCER
PCT/FR1994/001177 WO1995010299A1 (fr) 1993-10-08 1994-10-07 COMPOSITION DESTINEE A L'IMMUNOTHERAPIE D'UN CANCER SECRETANT L'hCG OU DES FRAGMENTS D'hCG
AU79413/94A AU7941394A (en) 1993-10-08 1994-10-07 Composition for treatment by immunotherapy of a cancer secreting hcg or hcg fragments

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9312039A FR2710845B1 (fr) 1993-10-08 1993-10-08 Composition destinée à l'immunothérapie d'un cancer sécrétant l'hCG ou des fragments d'hCG.

Publications (2)

Publication Number Publication Date
FR2710845A1 FR2710845A1 (fr) 1995-04-14
FR2710845B1 true FR2710845B1 (fr) 1996-03-29

Family

ID=9451685

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9312039A Expired - Fee Related FR2710845B1 (fr) 1993-03-11 1993-10-08 Composition destinée à l'immunothérapie d'un cancer sécrétant l'hCG ou des fragments d'hCG.

Country Status (3)

Country Link
AU (1) AU7941394A (fr)
FR (1) FR2710845B1 (fr)
WO (1) WO1995010299A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1970381B1 (fr) * 2007-03-14 2009-11-18 Montco Cancer Research B.V. Agent de modulation immunitaire anti-cancéreux

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4201770A (en) * 1973-05-07 1980-05-06 The Ohio State University Antigenic modification of polypeptides
US4234561A (en) * 1978-02-06 1980-11-18 Research Corporation Antigen for early pregnancy test and contraceptive vaccine
FR2623715B1 (fr) * 1987-11-26 1990-12-21 Lafon Labor Structures peptidiques, immunogenes les contenant et leurs applications au controle de la fertilite
US6225449B1 (en) * 1991-10-04 2001-05-01 Washington University Hormone analogs with multiple CTP extensions
CA2045842A1 (fr) * 1990-07-16 1992-01-17 William R. Jacobs Adn capable de s'integrer dans un site particulier de mycobacteries
AU681572B2 (en) * 1991-10-21 1997-09-04 Med Immune, Inc. Bacterial expression vectors containing DNA encoding secretion signals of lipoproteins
US5985611A (en) * 1992-04-30 1999-11-16 Washington University Recombinant production of gonadotropins in secretory cells

Also Published As

Publication number Publication date
WO1995010299A1 (fr) 1995-04-20
FR2710845A1 (fr) 1995-04-14
AU7941394A (en) 1995-05-04

Similar Documents

Publication Publication Date Title
GR3023762T3 (en) Cement composition.
EP0618344A3 (fr) Composition de ciment utilisable au fond de points.
FR2704135B1 (fr) Agrafe d'osteosynthese.
EP0627932A4 (fr) Nouvelle structure d'anticorps.
GR3030458T3 (en) Fungicidal mixture.
EP0625618A3 (fr) Panneau de façade.
FR2712491B1 (fr) Compositions antisudorales.
EP0614944A3 (fr) Composition intumescente du type deux-composantes.
ZA931773B (en) Substituted phenylacetamides.
FR2705415B1 (fr) Disque d'embrayage.
FI941776A0 (fi) Menetelmä 1,2,4-tiadiatsolien valmistamiseksi
EP0664115A3 (fr) Composition de shampoing.
ZA931772B (en) Imidazolyl-substituted phenylacetamides.
EP0607658A3 (fr) Fabrication d'un MOSFET.
FR2710845B1 (fr) Composition destinée à l'immunothérapie d'un cancer sécrétant l'hCG ou des fragments d'hCG.
GB2277039A8 (en) Curling stones & the like
FR2710388B1 (fr) Vanne d'arrêt.
EP0562125A4 (fr) Composition a base d'anticorps.
FR2707464B1 (fr) Perfectionnement aux articles chaussants.
EP0640621A3 (fr) Anticorps monoclonal anti-thrombine.
FI953833A (fi) Murskain
EP0654532A4 (fr) Anticorps monoclonal antimucoglycoproteine.
FR2670163B1 (fr) Ensemble pour la transformation d'une camionnette en arroseuse.
FR2713434B1 (fr) Billonneur-sillonneur destiné à la culture de l'igname.
ITRM930338A0 (it) Raccoglitore per istruzioni per l'utilizzo di mezzi di organizzazione.

Legal Events

Date Code Title Description
ST Notification of lapse